Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.

Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.

TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.

We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.

To date, over 4.2 million patient procedures are recorded.

Latest Media Releases

Cyclopharm (ASX:CYC) Company Update

24/03/2020 12:38:00

COVID-19 Virus likely to increase use of Technegas® US FDA New Drug Application for Technegas – Application ready to submit to FDA Litigation – Statement of Claim Lodged with th…

Latest News